Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
LAE-005 by Laekna for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
LAE-005 is under clinical development by Laekna and currently in Phase I for Triple-Negative Breast Cancer (TNBC). According to GlobalData,...
Data Insights
LAE-005 by Laekna for Solid Tumor: Likelihood of Approval
LAE-005 is under clinical development by Laekna and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...